“It is crucial that all people over 60 and all vulnerable people are given a second booster dose as soon as possible,” said the European Commissioner for Health.

On Monday, EU health agencies recommended a second COVID-19 reminder for all over 60s just as Europe is experiencing a new wave of infections and increasing hospitalizations.

While existing coronavirus vaccines continue to provide good protection against hospitalization and death, the vaccine’s effectiveness took a hit how the virus evolved.

“It is imperative that all people over the age of 60 and all vulnerable people show up for a second booster dose as soon as possible.”European Commissioner for Health Stella Kyriakides said in a statement.

Accelerate vaccination campaigns

EU health agencies have recommended a second recall since April only for people over 80 and the most vulnerable.

The new recommendation should facilitate national decisions to speed up vaccination campaignsthat have stopped in recent months.

“We are currently seeing an increase in reporting rates of COVID-19 cases and an upward trend in hospital and ICU admissions and employment in several countries, mainly due to Stresses Omicron’s BA 5said in a statement Dr. Andrea Ammon, director of ECDC.



BRUSSELS / LONDON, July 11 (Reuters) – European Union health agencies on Monday recommended a second recall of COVID-19 for all people over the age of 60 in a further increase in infections and hospitalizations across Europe.

While existing coronavirus vaccines continue to provide good protection against hospitalization and death, the vaccine’s effectiveness has taken a hit with the evolution of the virus.

“It is imperative that all people over 60 and all vulnerable people receive a second booster dose as soon as possible,” European Health Commissioner Stella Kyriakides said in a statement.

EU health agencies have recommended a second recall since April only for people over 80 and the most vulnerable.

The new recommendation should facilitate national decisions to speed up vaccination campaigns, which have slowed down in recent months.

“We are currently seeing an increase in reporting rates of COVID-19 cases and an increasing trend in hospital and intensive care admissions and employment in several countries, mainly due to the BA 5 d. ‘Omicron stresses.” ECDC Director Dr Andrea Ammon said in a statement. .

Vaccine manufacturers, such as Moderna, Pfizer Inc, or BioNTech, have tested modified versions of their vaccines to combat the Omicron BA.1 variant.

Although they claimed that these vaccines generated a good immune response against BA.1 and circulating variants more recently, they observed a weaker response against BA.4 and BA.5.

The EMA, which is currently examining two vaccines paired with the variants, expects the first next-generation vaccines to be approved by September.

Read also:
Covid – Beijing abandons mandatory vaccination for access to public places

Read also:
Covid: hospitalizations, epidemic peak … what do the new projections of the Institut Pasteur predict?

Read also:
Covid vaccines: are you affected by the 4th dose?

Read also:
Covid: with the new Centauro variant, the epidemic is already setting the tone for the next few months

Read also:
Covid: Israel launches vaccination of children over 6 months, with Pfizer and Moderna

#Covid #European #Union #recommends #booster #dose

Leave a Reply

Your email address will not be published.